Cargando…

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Detalles Bibliográficos
Autores principales: Chen, Yusi, Luo, Jun, Chen, Jingyuan, Kotlyar, Eugene, Li, Zilu, Chen, Wenjie, Li, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035514/
https://www.ncbi.nlm.nih.gov/pubmed/35479317
http://dx.doi.org/10.3389/fphar.2022.891907
_version_ 1784693308712288256
author Chen, Yusi
Luo, Jun
Chen, Jingyuan
Kotlyar, Eugene
Li, Zilu
Chen, Wenjie
Li, Jiang
author_facet Chen, Yusi
Luo, Jun
Chen, Jingyuan
Kotlyar, Eugene
Li, Zilu
Chen, Wenjie
Li, Jiang
author_sort Chen, Yusi
collection PubMed
description
format Online
Article
Text
id pubmed-9035514
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90355142022-04-26 Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study Chen, Yusi Luo, Jun Chen, Jingyuan Kotlyar, Eugene Li, Zilu Chen, Wenjie Li, Jiang Front Pharmacol Pharmacology Frontiers Media S.A. 2022-04-11 /pmc/articles/PMC9035514/ /pubmed/35479317 http://dx.doi.org/10.3389/fphar.2022.891907 Text en Copyright © 2022 Chen, Luo, Chen, Kotlyar, Li, Chen and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Chen, Yusi
Luo, Jun
Chen, Jingyuan
Kotlyar, Eugene
Li, Zilu
Chen, Wenjie
Li, Jiang
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
title Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
title_full Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
title_fullStr Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
title_full_unstemmed Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
title_short Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
title_sort corrigendum: the transition from ambrisentan to macitentan in patients with pulmonary arterial hypertension: a real-word prospective study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035514/
https://www.ncbi.nlm.nih.gov/pubmed/35479317
http://dx.doi.org/10.3389/fphar.2022.891907
work_keys_str_mv AT chenyusi corrigendumthetransitionfromambrisentantomacitentaninpatientswithpulmonaryarterialhypertensionarealwordprospectivestudy
AT luojun corrigendumthetransitionfromambrisentantomacitentaninpatientswithpulmonaryarterialhypertensionarealwordprospectivestudy
AT chenjingyuan corrigendumthetransitionfromambrisentantomacitentaninpatientswithpulmonaryarterialhypertensionarealwordprospectivestudy
AT kotlyareugene corrigendumthetransitionfromambrisentantomacitentaninpatientswithpulmonaryarterialhypertensionarealwordprospectivestudy
AT lizilu corrigendumthetransitionfromambrisentantomacitentaninpatientswithpulmonaryarterialhypertensionarealwordprospectivestudy
AT chenwenjie corrigendumthetransitionfromambrisentantomacitentaninpatientswithpulmonaryarterialhypertensionarealwordprospectivestudy
AT lijiang corrigendumthetransitionfromambrisentantomacitentaninpatientswithpulmonaryarterialhypertensionarealwordprospectivestudy